Additional Information
Book Details
Abstract
Combining essential hematology content with the diagnostic features of an atlas, Veterinary Hematology: A Diagnostic Guide and Color Atlas delivers all the information you need to accurately assess and diagnose the blood diseases of common domestic animals — including dogs, cats, horses, cattle, sheep, goats, pigs, and llamas. This all-in-one resource utilizes a clinically-oriented and user-friendly approach to guide you through the processes of selecting relevant diagnostic tests, collecting and preparing samples, interpreting sample results, and determining their clinical significance. High-resolution photomicrographs, full-color illustrations, and excellent schematic drawings, tables, and quick-reference algorithms help you clearly visualize these concepts and procedures.
- Two books in one gives you the information of a user-friendly, clinical textbook and the diagnostic features of a color atlas in a single reference.
- Practical, clinically-relevant text is comprehensive and yet concise in its delivery of vital information such as:
- Principles and procedures that are employed in recognizing normal, abnormal, and artifactual features of blood and bone marrow samples and developing accurate diagnoses
- Common cytochemical stains and summary charts for interpretation
- Sample collection, staining procedures, and diagnostic techniques
- Differentiating features of malignant and benign hematologic disorders
- Miscellaneous cells and blood parasites and their significance in the evaluation of blood smears
- Hematopoietic and non-hematopoietic neoplasms
- High- resolution photomicrographs and excellent schematic drawings, tables, boxes and quick-reference algorithms aid your understanding of basic clinical concepts and differential diagnostic considerations.
- Over 800 full-color illustrations help you clearly visualize the concepts and clinical features of the blood and bone marrow — from normal cell maturation to the development of various pathologies.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | cover | ||
Inside Front Cover | ifc1 | ||
Veterinary Hematology | i | ||
Copyright Page | ii | ||
Dedication | iii | ||
Foreword Benefits for the Veterinarian and the Veterinary Clinical Pathologist | iv | ||
Foreword Benefits for the Veterinary Technician | v | ||
Preface | vi | ||
Acknowledgments | vii | ||
Table Of Contents | viii | ||
1 Introduction to Veterinary Hematology | 1 | ||
Internal Versus External Laboratories | 1 | ||
Reference Intervals | 2 | ||
Selection of Reference Animals | 2 | ||
Determination of Reference Intervals | 2 | ||
Interpretation of Test Results Relative to Reference Intervals | 3 | ||
Use of Published Reference Intervals | 3 | ||
Sensitivity and Specificity of Tests | 3 | ||
Predictive Values and Disease Prevalence | 4 | ||
Cutoff Values | 6 | ||
Accuracy Versus Precision | 6 | ||
Automated versus Manual Methods | 8 | ||
Critical Difference | 9 | ||
References | 10 | ||
2 Hematology Procedures | 11 | ||
Composition of Blood | 11 | ||
Calculation of Blood Volume | 11 | ||
Sample Collection and Handling | 11 | ||
Gross Examination of Blood Samples | 12 | ||
Methemoglobinemia | 12 | ||
Erythrocyte Agglutination | 13 | ||
Microhematocrit Tube Evaluation | 14 | ||
Packed Cells | 15 | ||
The Appearance of Plasma | 15 | ||
Plasma Protein Determination | 15 | ||
Fibrinogen Determination | 16 | ||
Blood Cell Counting and Sizing | 16 | ||
Manual Cell Counting | 16 | ||
Automated Cell Counting | 17 | ||
Errors in Blood Cell Counting and Sizing | 17 | ||
Quality Control | 18 | ||
Blood-Film Preparation | 18 | ||
Glass-Slide Blood-Film Method | 18 | ||
Coverslip Blood-Film Method | 19 | ||
Blood-Film Staining Procedures | 19 | ||
Romanowsky-Type Stains | 19 | ||
Reticulocyte Stains | 21 | ||
New Methylene Blue “Wet Mounts” | 22 | ||
Iron Stains | 22 | ||
Cytochemical Stains | 23 | ||
Examination of Stained Blood Films | 23 | ||
Leukocyte Evaluation | 24 | ||
Erythrocyte Morphology | 26 | ||
Platelets | 26 | ||
Degenerative Changes in Blood Samples | 27 | ||
Infectious Agents or Inclusions of Blood Cells | 27 | ||
Miscellaneous Cells and Parasites in Blood | 28 | ||
Mitotic Cells | 28 | ||
Free Nuclei | 28 | ||
Endothelial Cells | 28 | ||
Megakaryocytes | 28 | ||
Microfilaria | 29 | ||
Trypanosoma Species | 29 | ||
Bacteria | 30 | ||
References | 30 | ||
3 Hematopoiesis | 33 | ||
Overview | 33 | ||
Sites of Blood Cell Production | 33 | ||
Organization of Bone Marrow | 33 | ||
Hematopoietic Stem Cells and Progenitor Cells | 34 | ||
Mesenchymal Stem Cells | 35 | ||
Homing of Hematopoietic Stem Cells and Progenitor Cells to the Marrow | 37 | ||
Hematopoietic Microenvironment | 37 | ||
Hematopoietic Growth Factors | 38 | ||
Erythropoiesis | 38 | ||
Primitive Erythropoiesis | 38 | ||
Hematopoietic Progenitor Cells and the Bone Marrow Microenvironment | 38 | ||
Nutrients Needed for Erythropoiesis | 39 | ||
Maturation of Erythroid Cells | 39 | ||
Control of Erythropoiesis | 41 | ||
Leukopoiesis | 42 | ||
Neutrophil Production | 42 | ||
Eosinophil, Basophil, and Mast Cell Production | 43 | ||
Production of Monocytes, Macrophages, Dendritic Cells, and Osteoclasts | 43 | ||
Lymphocyte and NK Cell Production | 44 | ||
Thrombopoiesis | 45 | ||
References | 45 | ||
4 Evaluation of Erythrocytes | 49 | ||
Normal Erythrocytes | 49 | ||
Erythrocyte Morphology | 49 | ||
Erythrocyte Functions | 49 | ||
Erythrocyte Biochemistry | 50 | ||
Membrane Structure and Function | 50 | ||
ATP Generation | 51 | ||
2,3DPG Pathway | 52 | ||
Oxidant Injury | 52 | ||
Protection against Oxidant Injury. | 52 | ||
Methemoglobin Formation and Reduction | 54 | ||
Iron Metabolism | 54 | ||
Iron Absorption. | 54 | ||
Systemic Control of Iron Metabolism. | 56 | ||
Plasma Iron. | 56 | ||
Iron Uptake by Erythroid Cells. | 56 | ||
Macrophage Iron Metabolism. | 56 | ||
Erythrocyte Destruction | 57 | ||
Normal Removal of Aged Erythrocytes | 57 | ||
Pathologic Destruction of Erythrocytes | 58 | ||
Abnormal Erythrocyte Morphology | 59 | ||
Rouleaux | 59 | ||
Agglutination | 59 | ||
Polychromasia | 59 | ||
Anisocytosis | 61 | ||
Hypochromasia | 62 | ||
Poikilocytosis | 63 | ||
Echinocytes (Crenated Erythrocytes) | 65 | ||
Acanthocytes | 66 | ||
Keratocytes | 67 | ||
Stomatocytes | 67 | ||
Spherocytes | 68 | ||
Schistocytes | 69 | ||
Leptocytes | 70 | ||
Eccentrocytes | 70 | ||
Pyknocytes | 71 | ||
Elliptocytes (Ovalocytes) | 71 | ||
Dacryocytes | 73 | ||
Drepanocytes (Sickle Cells) | 73 | ||
Crystallized Hemoglobin | 75 | ||
Lysed Erythrocytes | 76 | ||
Erythroid Loops | 76 | ||
Erythrocyte Vesicles | 76 | ||
Nucleated Erythrocytes | 78 | ||
Inclusions of Erythrocytes | 79 | ||
Howell-Jolly Bodies (Micronuclei) | 79 | ||
Heinz Bodies | 79 | ||
Basophilic Stippling | 80 | ||
Siderotic Inclusions | 80 | ||
Cabot Rings | 82 | ||
Infectious Agents of Erythrocytes | 82 | ||
Babesia Species | 82 | ||
Theileria Species | 86 | ||
Cytauxzoon felis | 86 | ||
Anaplasma Species | 86 | ||
Distemper Inclusions | 86 | ||
Hemotropic Mycoplasmas (Hemoplasmas) | 87 | ||
Bartonella Species | 90 | ||
Artifacts Resembling Infectious Agents | 90 | ||
Erythrocyte Assays | 90 | ||
Erythrocyte Counts, Hematocrit, and Hemoglobin Content | 90 | ||
Reticulocyte Counts | 91 | ||
Erythrocyte Indices | 93 | ||
Mean Cell Volume | 93 | ||
Mean Cell Hemoglobin Concentration | 94 | ||
Mean Cell Hemoglobin | 95 | ||
Red Cell Distribution Width | 95 | ||
Erythrocyte Volume Histograms and Erythrocyte Cytograms | 96 | ||
Direct Antiglobulin Test | 96 | ||
Methemoglobin Determination | 96 | ||
Toxic Methemoglobinemia | 97 | ||
Cytochrome-b5 Reductase Deficiency | 97 | ||
Serum Iron Assays | 97 | ||
Serum Iron | 97 | ||
Total Iron-Binding Capacity | 98 | ||
Serum Ferritin | 98 | ||
Erythropoietin Assay | 98 | ||
Differential Diagnosis of Anemia | 98 | ||
Regenerative Versus Nonregenerative Anemia | 99 | ||
Classification of Anemia Using Erythrocyte Indices | 99 | ||
Hemolytic Anemias | 99 | ||
Immune-Mediated Hemolytic Anemia | 101 | ||
Primary IMHA | 101 | ||
Neonatal Isoerythrolysis | 101 | ||
Transfusion Reactions | 101 | ||
Erythrocyte Parasites | 102 | ||
Babesia Species | 102 | ||
Theileria Species | 102 | ||
Cytauxzoon felis | 102 | ||
Anaplasma Species | 103 | ||
Hemotropic Mycoplasmas (Hemoplasmas) | 103 | ||
Other Infectious Agents | 103 | ||
Chemicals and Plants | 104 | ||
Oxidants | 104 | ||
Venoms | 104 | ||
Drugs Causing Immune-Mediated Anemia | 104 | ||
Fragmentation | 104 | ||
Hypo-osmolality | 104 | ||
Hypophosphatemia | 104 | ||
Hereditary Erythrocyte Defects | 105 | ||
Pyruvate Kinase Deficiency in Dogs and Cats | 105 | ||
Phosphofructokinase Deficiency in Dogs | 105 | ||
Increased Erythrocyte Osmotic Fragility in Cats | 105 | ||
Hereditary Spherocytosis in Cattle | 105 | ||
Glucose-6-Phosphate Dehydrogenase Deficiency in a Horse | 105 | ||
Erythrocyte Flavin Adenine Dinucleotide Deficiency in Horses | 106 | ||
Hereditary Stomatocytosis in Dogs | 106 | ||
Additional Hereditary Defects | 106 | ||
Miscellaneous Causes of Hemolytic Anemia | 106 | ||
Splenic Disorders | 106 | ||
Liver Failure in Horses | 106 | ||
Postparturient Hemoglobinuria in Dairy Cattle | 106 | ||
Blood-Loss Anemias | 106 | ||
Anemias Resulting from Decreased Erythrocyte Production | 107 | ||
Nonregenerative Anemias without Leukopenia or Thrombocytopenia | 108 | ||
Hormone Deficiencies | 108 | ||
Anemia of Inflammatory Disease (Anemia of Chronic Disease) | 108 | ||
Disorders of Nucleic Acid Synthesis | 108 | ||
Abnormalities in Heme Synthesis | 108 | ||
Nonregenerative Immune-Mediated Anemia | 109 | ||
Selective Erythroid Aplasia | 109 | ||
Dyserythropoiesis | 109 | ||
Nonregenerative Anemias with Leukopenia and/or Thrombocytopenia | 109 | ||
Hypocellular/Aplastic Bone Marrow | 109 | ||
Myelophthisic Disorders | 110 | ||
Physiologic Anemia of Neonatal Animals | 110 | ||
Erythrocytosis (Polycythemia) | 111 | ||
Relative Erythrocytosis | 111 | ||
Absolute Erythrocytosis | 112 | ||
Differential Diagnosis of Erythrocytosis | 112 | ||
References | 112 | ||
5 Evaluation of Leukocytic Disorders | 122 | ||
Leukocyte Types and Numbers in Blood | 122 | ||
Leukocyte Kinetics | 122 | ||
Neutrophils | 122 | ||
Eosinophils and Basophils | 124 | ||
Monocytes | 124 | ||
Lymphocytes | 124 | ||
Leukocyte Functions | 125 | ||
Neutrophil Functions | 125 | ||
Eosinophil Functions | 127 | ||
Basophil Functions | 128 | ||
Monocyte/Macrophage/Dendritic-Cell Functions | 129 | ||
Monocyte Functions | 129 | ||
Macrophage Functions | 129 | ||
Dendritic-Cell Functions | 129 | ||
Lymphocyte and NK Cell Functions | 130 | ||
CD4+ T Lymphocyte Functions | 130 | ||
CD8+ T Lymphocyte Functions | 130 | ||
B Lymphocyte Functions | 131 | ||
NK Cell Functions | 132 | ||
Neutrophils | 132 | ||
Normal Neutrophil Morphology | 132 | ||
Morphology of Left Shifts | 133 | ||
Myeloblasts | 133 | ||
Promyelocytes | 133 | ||
Myelocytes | 133 | ||
Metamyelocytes | 133 | ||
Band Neutrophils | 133 | ||
Disorders with Left Shifts | 134 | ||
Inflammation | 134 | ||
Chronic Myeloid Leukemia | 134 | ||
Pelger-Huët Anomaly (Hyposegmentation) | 134 | ||
Hypersegmentation | 135 | ||
Toxic Cytoplasm | 136 | ||
Foamy Basophilia | 137 | ||
Döhle Bodies | 137 | ||
Toxic Granulation | 137 | ||
Granules and Inclusions | 137 | ||
Normal Foals | 137 | ||
Lipemia in a Horse | 137 | ||
Lysosomal Storage Diseases | 137 | ||
Birman Cats | 137 | ||
Reddish Granulation in Cats | 137 | ||
Chédiak-Higashi Syndrome | 137 | ||
May-Hegglin Anomaly | 140 | ||
Siderotic Inclusions | 140 | ||
Infectious Agents | 140 | ||
Distemper Inclusions | 140 | ||
Rickettsial Species | 140 | ||
Hepatozoon Species | 142 | ||
Miscellaneous Bacteria, Fungi, and Protozoa | 143 | ||
Miscellaneous Neutrophil Morphologic Abnormalities | 143 | ||
Giant Neutrophils | 143 | ||
Karyolysis | 144 | ||
Pyknosis and Karyorrhexis | 144 | ||
Cytoplasmic Vacuoles | 144 | ||
Phagocytized Eosinophil Granules | 144 | ||
Stain Precipitation | 144 | ||
Neutrophilia | 144 | ||
Neutropenia | 146 | ||
Inherited Neutrophil Defects | 147 | ||
Chédiak-Higashi Syndrome | 147 | ||
β2 Integrin Adhesion Molecule Deficiencies | 148 | ||
Kindlin-3 Deficiency | 148 | ||
Unknown Neutrophil Function Defects | 148 | ||
Cyclic Hematopoiesis | 148 | ||
Eosinophils | 148 | ||
Eosinophil Morphology | 148 | ||
Eosinophilia | 150 | ||
Eosinopenia | 150 | ||
Basophils | 151 | ||
Basophil Morphology | 151 | ||
Basophilia | 151 | ||
Mast Cells | 151 | ||
Mast Cell Morphology | 151 | ||
Mastocytemia | 152 | ||
Monocytes | 153 | ||
Monocyte Morphology | 153 | ||
Monocytosis | 155 | ||
Lymphocytes | 156 | ||
Lymphocyte Morphology | 156 | ||
Normal Lymphocyte Morphology | 156 | ||
Reactive Lymphocytes | 157 | ||
Cytoplasmic Granules, Vacuoles, and Inclusions | 158 | ||
Neoplastic Large Granular Lymphocytes, Plasma Cells, and Mott Cells | 158 | ||
Lymphocytosis | 160 | ||
Lymphopenia | 162 | ||
Blast Cells or Poorly Differentiated Cells | 163 | ||
Lymphoblasts | 163 | ||
Myeloblasts | 165 | ||
Monoblasts | 165 | ||
Rubriblasts | 166 | ||
Megakaryoblasts | 166 | ||
Neoplastic Dendritic Cells | 167 | ||
Unclassified Blast Cells | 167 | ||
Metastatic Blast Cells | 167 | ||
References | 168 | ||
6 Immunohematology | 177 | ||
Immune System | 177 | ||
Innate Immunity | 177 | ||
Acquired Immunity | 177 | ||
Tests for Immune-Mediated Disorders | 177 | ||
Tests for Antierythrocyte Antibodies | 177 | ||
Direct Antiglobulin Test or Coombs’ Test | 177 | ||
Direct Immunofluorescence Flow Cytometry Assay | 178 | ||
Direct Enzyme-Linked Antiglobulin Test | 178 | ||
Blood Typing | 178 | ||
Blood Cross-Match Tests | 179 | ||
Tests for Antinuclear Antibodies | 179 | ||
ANA Test | 179 | ||
Lupus Erythematosus Cell Test | 180 | ||
Tests for Antiplatelet Antibodies | 180 | ||
Primary Immune-Mediated Disorders | 180 | ||
Transfusion Reactions | 181 | ||
Neonatal Isoerythrolysis | 181 | ||
Primary Immune-Mediated Hemolytic Anemia | 181 | ||
Primary Immune-Mediated Thrombocytopenia | 182 | ||
Primary Immune-Mediated Neutropenia | 183 | ||
Systemic Lupus Erythematosus | 183 | ||
Tests for Immune Deficiency Disorders | 184 | ||
Neutrophil Function Tests | 184 | ||
Lymphocyte Assays | 184 | ||
Serum Immunoglobulin Assays | 184 | ||
Immunodeficiency Disorders | 185 | ||
Clinical Signs | 185 | ||
Inherited Neutrophil Defects | 185 | ||
Severe Combined Immunodeficiency | 185 | ||
Severe Combined Immunodeficiency Syndrome in Arabian Foals | 185 | ||
Severe Combined Immunodeficiency Syndrome in Jack Russell Terriers | 185 | ||
X-linked Severe Combined Immunodeficiency Syndrome in Dogs | 185 | ||
Serum Immunoglobulin Deficiencies | 186 | ||
Common Variable Immunodeficiency | 186 | ||
Fell Pony Syndrome | 186 | ||
Selective Immunoglobulin Deficiencies | 186 | ||
Immunodeficiency in Cavalier King Charles Spaniels | 186 | ||
X-linked Agammaglobulinemia in Foals | 186 | ||
Immunodeficiency in Weimaraner Dogs | 186 | ||
Transient Hypogammaglobulinemia in Neonates | 186 | ||
T Lymphocyte Immunodeficiency | 186 | ||
T Lymphocyte Immunodeficiency in Growth Hormone-Deficient Dogs | 186 | ||
Hypotrichosis with Thymic Aplasia in Cats | 186 | ||
Lethal Acrodermatitis in English Bull Terriers | 187 | ||
Complement Deficiency in Brittany Spaniel Dogs | 187 | ||
Viral Immune Deficiency Disorders | 187 | ||
Failure of Passive Transfer of Immunoglobulins | 187 | ||
References | 187 | ||
7 Evaluation of Hemostasis: | 191 | ||
Blood Platelets (Thrombocytes) | 191 | ||
Normal Morphology | 191 | ||
Platelet Life Span and Counts in Blood | 191 | ||
Platelet Metabolism | 192 | ||
Primary Hemostasis | 194 | ||
Vascular Phase | 194 | ||
Platelet Phase | 194 | ||
Platelet Adhesion | 194 | ||
Platelet Activation | 195 | ||
Change in Platelet Shape | 196 | ||
Platelet Secretion | 196 | ||
Platelet Aggregation | 196 | ||
Platelet Procoagulant Activity | 197 | ||
Secondary Hemostasis | 198 | ||
Overview | 198 | ||
Initiation of Coagulation (Activation of the Extrinsic Pathway or Tissue Factor Pathway) | 198 | ||
Amplification of Coagulation | 199 | ||
Propagation of Coagulation (Activity of the Intrinsic Pathway) | 199 | ||
Factor XII Activation of Factor XI | 199 | ||
Thrombin Activation of FXI | 200 | ||
Stabilization of the Thrombus | 200 | ||
Inhibitors of Thrombus Formation | 201 | ||
Inhibition of Platelet Aggregation | 201 | ||
Antithrombin | 201 | ||
Protein C Anticoagulant Pathway | 201 | ||
Tissue Factor Pathway Inhibitor | 201 | ||
Platelet-Secreted Inhibitors | 201 | ||
Additional Coagulation Inhibitors | 201 | ||
Fibrinolysis | 202 | ||
Anticoagulants | 202 | ||
Screening Tests For Hemostatic Disorders | 203 | ||
Platelet Count | 203 | ||
Mean Platelet Volume | 203 | ||
Bleeding Time | 204 | ||
Activated Clotting Time | 204 | ||
Activated Partial Thromboplastin Time | 204 | ||
Prothrombin Time | 205 | ||
Thrombin Clotting Time | 205 | ||
Fibrinogen | 205 | ||
Fibrin(ogen) Degradation Products and D-Dimer Assays | 205 | ||
FDP Assays | 205 | ||
D-Dimer Assays | 206 | ||
Thromboelastography | 206 | ||
Specialized Tests for Hemostatic Disorders | 207 | ||
von Willebrand Factor | 207 | ||
Antithrombin | 207 | ||
PIVKA (Proteins Induced by Vitamin K Absence or Antagonism) | 207 | ||
Reticulated Platelet Count | 207 | ||
Platelet Function | 208 | ||
Flow Cytometry | 208 | ||
Platelet Function Analyzer | 208 | ||
Platelet Aggregation | 208 | ||
Platelet Secretion | 208 | ||
Antiplatelet Antibody | 208 | ||
Specific Coagulation Factors | 209 | ||
Clinical Signs Of Hemostatic Disorders | 209 | ||
Platelet Disorders | 209 | ||
Abnormal Platelet Morphology | 209 | ||
Macrothrombocytes | 209 | ||
Activated Platelets | 209 | ||
Hypogranular Platelets | 210 | ||
Anaplasma platys Infection | 210 | ||
Thrombocytopenia | 211 | ||
Decreased Platelet Production | 213 | ||
Increased Platelet Utilization | 213 | ||
Increased Platelet Destruction | 214 | ||
Sequestration of Platelets | 214 | ||
Massive External Hemorrhage | 214 | ||
Infections and Thrombocytopenia | 215 | ||
Drug- and Chemical-Induced Thrombocytopenia | 215 | ||
Neoplasia and Thrombocytopenia | 216 | ||
Inherited Thrombocytopenia | 216 | ||
Pseudothrombocytopenia | 216 | ||
Abnormalities in Platelet Function Acquired Defects in Platelet Function | 216 | ||
Inherited Platelet Function Defects | 217 | ||
von Willebrand Disease | 217 | ||
Thrombocytosis | 218 | ||
Coagulation Disorders | 219 | ||
Acquired Coagulation Disorders | 219 | ||
Hypercoagulable State | 219 | ||
Thromboembolism (Localized Thrombosis) | 219 | ||
Disseminated Intravascular Coagulation | 220 | ||
Hemolytic-Uremic Syndrome | 221 | ||
Antiphospholipid Antibody | 221 | ||
Liver Disease | 222 | ||
Vitamin K Deficiency | 222 | ||
Snake Venoms | 222 | ||
Hereditary Coagulation Disorders | 223 | ||
Factor XII and Prekallikrein Deficiencies | 223 | ||
Factor XI Deficiency | 223 | ||
Factor IX and Factor VIII Deficiencies | 223 | ||
Factor VII Deficiency | 223 | ||
Defects in the Common Coagulation Pathway | 223 | ||
Vitamin K-Dependent Coagulopathies | 223 | ||
Interpretation Of Hemostatic Test Profiles | 224 | ||
References | 224 | ||
8 Bone Marrow Examination | 234 | ||
Reasons to Examine Bone Marrow | 234 | ||
Sites for Bone Marrow Biopsy | 234 | ||
Ilium | 234 | ||
Proximal Femur | 234 | ||
Proximal Humerus | 235 | ||
Sternum | 235 | ||
Proximal Ribs | 235 | ||
Other Sites | 235 | ||
Technique of Bone Marrow Aspiration | 235 | ||
Technique of Bone Marrow Core Biopsy | 238 | ||
Morphologic Identification of Cells | 240 | ||
Megakaryocytic Series | 240 | ||
Erythrocytic Series | 240 | ||
Rubriblasts | 240 | ||
Prorubricytes | 242 | ||
Basophilic Rubricytes | 242 | ||
Polychromatophilic Rubricytes | 242 | ||
Metarubricytes | 242 | ||
Polychromatophilic Erythrocytes (Reticulocytes) | 242 | ||
Granulocytic Series | 242 | ||
Myeloblasts | 242 | ||
Promyelocytes (Progranulocytes) | 242 | ||
Myelocytes | 242 | ||
Metamyelocytes | 243 | ||
Band Cells | 243 | ||
Segmented Granulocytes | 243 | ||
Monocytic Series | 243 | ||
Macrophages | 244 | ||
Lymphocytes | 245 | ||
Plasma Cells | 245 | ||
Osteoclasts | 247 | ||
Osteoblasts | 247 | ||
Mitotic Figures | 247 | ||
Miscellaneous Cells and Free Nuclei | 248 | ||
Organized Approach to Bone Marrow Evaluation | 250 | ||
Cellularity | 251 | ||
Megakaryocytes | 251 | ||
Erythroid Cells | 254 | ||
Granulocytic Cells | 254 | ||
Myeloid-to-Erythroid Ratio | 254 | ||
Lymphocytes | 254 | ||
Plasma Cells | 255 | ||
Mononuclear Phagocytes | 255 | ||
Other Cell Types | 255 | ||
Stainable Iron | 256 | ||
Interpretation | 258 | ||
References | 258 | ||
9 Disorders of Bone Marrow | 260 | ||
Generalized Increases in Hematopoietic Cells | 260 | ||
Generalized Decreases In Hematopoietic Cells | 260 | ||
Hypocellular/Aplastic Bone Marrow | 260 | ||
Acute Bone Marrow Injury and Necrosis | 263 | ||
Gelatinous Transformation of Bone Marrow | 264 | ||
Myelofibrosis | 265 | ||
Generalized Osteosclerosis/Hyperostosis | 268 | ||
Abnormalities of The Erythroid Series | 268 | ||
Erythroid Hyperplasia | 268 | ||
Selective Erythroid Hypoplasia or Aplasia | 270 | ||
Dyserythropoiesis | 273 | ||
Abnormalities of The Granulocytic Series | 275 | ||
Granulocytic Hyperplasia | 275 | ||
Neutrophilic Hyperplasia | 275 | ||
Eosinophilic Hyperplasia | 277 | ||
Basophilic Hyperplasia | 278 | ||
Granulocytic Hypoplasia | 278 | ||
Selective Neutrophilic Hypoplasia or Aplasia | 279 | ||
Dysgranulopoiesis | 280 | ||
Abnormalities of Megakaryocytes | 283 | ||
Megakaryocytic Hyperplasia | 283 | ||
Selective Megakaryocytic Hypoplasia or Aplasia | 284 | ||
Dysmegakaryocytopoiesis | 284 | ||
Emperipolesis | 285 | ||
Abnormalities of Mononuclear Phagocytes | 286 | ||
Monocytic Hyperplasia | 286 | ||
Reactive Macrophage Hyperplasia | 286 | ||
Phagocytosis of Blood Cells and Their Precursors | 286 | ||
Histiocytic Sarcoma | 293 | ||
Inflammatory Disorders of Bone Marrow | 293 | ||
Acute Inflammation | 293 | ||
Fibrinous Inflammation | 293 | ||
Chronic Inflammation/Hyperplasia | 294 | ||
Chronic Granulomatous Inflammation | 294 | ||
Hematopoietic Neoplasms | 296 | ||
Lymphoid Neoplasms | 298 | ||
Acute Lymphoblastic Leukemia | 298 | ||
Chronic Lymphocytic Leukemia | 300 | ||
Lymphomas | 301 | ||
Multiple Myeloma and Other Immunoproliferative Neoplasms | 302 | ||
Multiple Myeloma | 302 | ||
Extramedullary Plasmacytoma | 305 | ||
Other B Lymphocyte Neoplasms | 305 | ||
Myeloid Neoplasms | 306 | ||
Myelodysplastic Syndromes | 307 | ||
Acute Myeloid Leukemias | 309 | ||
AML-M1 | 309 | ||
AML-M2 | 309 | ||
AML-M3 | 311 | ||
AML-M4 | 311 | ||
AML-M5 | 311 | ||
AML-M6 | 312 | ||
AML-M7 | 312 | ||
Acute Undifferentiated Leukemia | 313 | ||
Peripheral Blood Findings | 313 | ||
Frequency in Animal Species | 313 | ||
Myeloproliferative Neoplasms | 314 | ||
Chronic Myeloid Leukemia | 314 | ||
Eosinophilic Leukemia | 315 | ||
Basophilic Leukemia | 315 | ||
Primary Erythrocytosis | 315 | ||
Essential Thrombocythemia | 315 | ||
Nonhematopoietic Neoplasms | 315 | ||
Mast Cell Tumors | 316 | ||
Metastatic Neoplasms | 316 | ||
Sarcomas of Bone | 317 | ||
References | 318 | ||
Appendix I Tables | 328 | ||
Example of Bone Marrow Evaluation and Interpretation | 328 | ||
Appendix II Algorithms | 336 | ||
Appendix III Case Studies | 343 | ||
Case 1: Estrogen-Induced Aplastic Anemia | 343 | ||
Notable Laboratory Findings | 343 | ||
Assessment | 343 | ||
Comment | 343 | ||
References | 343 | ||
Case 2: Acute Lymphoblastic Leukemia | 344 | ||
Notable Laboratory Findings | 344 | ||
Assessment | 344 | ||
Comment | 344 | ||
Reference | 344 | ||
Case 3: Iron-Deficiency Anemia | 345 | ||
Notable Laboratory Findings | 345 | ||
Assessment | 345 | ||
Comment | 345 | ||
Reference | 345 | ||
Case 4: Mycoplasma Haemofelis Infection | 346 | ||
Notable Laboratory Findings | 346 | ||
Assessment | 346 | ||
Comment | 346 | ||
Reference | 346 | ||
Case 5: Vaginal Tear | 347 | ||
Notable Laboratory Findings (Day 1) | 347 | ||
Index | 351 | ||
A | 351 | ||
B | 352 | ||
C | 352 | ||
D | 353 | ||
E | 353 | ||
F | 354 | ||
G | 354 | ||
H | 355 | ||
I | 355 | ||
J | 356 | ||
K | 356 | ||
L | 356 | ||
M | 356 | ||
N | 357 | ||
O | 358 | ||
P | 358 | ||
Q | 359 | ||
R | 359 | ||
S | 359 | ||
T | 359 | ||
U | 360 | ||
V | 360 | ||
W | 360 | ||
X | 360 |